Senior insider sale
Chief Business Officer at PTC THERAPEUTICS, INC. — senior position signals high conviction
$5.88M
77.51K shares
PAUWELS ERIC plans to sell 77.51K shares of PTC THERAPEUTICS, INC. valued at approximately $5.88M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Vesting
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/17/2026 | Restricted Stock Vesting Compensation | 3.02K | — |
| Total | 3.02K | ||
Completed
Units to sell
2.75K
Market value
$213.9K
Units to sell
4.60K
Market value
$352.1K
Units to sell
1.35K
Market value
$104.8K
Units to sell
1.79K
Market value
$137.7K
Units to sell
20.51K
Market value
$1.58M
Units to sell
3.20K
Market value
$240.4K
Units to sell
40.29K
Market value
$3.04M
Planned — Approximate Date
Units to sell
3.02K
Market value
$209.4K
Units
77.51K
Value
$5.88M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/9/2026 | 2.75K | $213.9K | — | Completed |
1/8/2026 | 4.60K | $352.1K | — | Completed |
1/7/2026 | 1.35K | $104.8K | — | Completed |
1/6/2026 | 1.79K | $137.7K | — | Completed |
12/19/2025 | 20.51K | $1.58M | — | Completed |
12/18/2025 | 3.20K | $240.4K | — | Completed |
12/17/2025 | 40.29K | $3.04M | — | Completed |
| Planned — Approximate Date | ||||
2/18/2026 | 3.02K | $209.4K | NASDAQ | Planned |
| Total | 77.51K | $5.88M | ||